Abich Financial Wealth Management LLC Crinetics Pharmaceuticals, Inc. Transaction History
Abich Financial Wealth Management LLC
- $281 Billion
- Q3 2025
A detailed history of Abich Financial Wealth Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 1,632 shares of CRNX stock, worth $70,078. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,632Holding current value
$70,078% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CRNX
# of Institutions
240Shares Held
91.2MCall Options Held
59.7KPut Options Held
14.8K-
Vanguard Group Inc Valley Forge, PA9.17MShares$394 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.4MShares$275 Million1.78% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$268 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.81MShares$249 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.59MShares$240 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.31B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...